Blood

Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable.

Blood

Kogan SC, Hong SH, Shultz DB, Privalsky ML, Bishop JM

Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable.

Blood

Kogan SC, Hong SH, Shultz DB, Privalsky ML, Bishop JM

Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and Do not exhibit a Bernard-Soulier phenotype.

Blood

Kahn ML, Diacovo TG, Bainton DF, Lanza F, Trejo J, Coughlin SR

The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit.

Blood

Berrozpe G, Timokhina I, Yukl S, Tajima Y, Ono M, Zelenetz AD, Besmer P

Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero.

Blood

Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M

Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero.

Blood

Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M

Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.

Blood

Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT

Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.

Blood

Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT

Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling.

Blood

Ho JM, Beattie BK, Squire JA, Frank DA, Barber DL

Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling.

Blood

Ho JM, Beattie BK, Squire JA, Frank DA, Barber DL

Pages